Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
US Food and Drug Administration (FDA) Approves Henlius and Organon's BILDYOS® (denosumab-nxxp) and BILPREVDA® (denosumab-nxxp), Biosimilars to PROLIA (denosumab) and XGEVA (denosumab), Respectively 2025-09-02 21:10
Seegene and Springer Nature Open Applications for 2025-2026 Nature Awards MDx Impact Grants 2025-09-02 21:00
SK bioscience Submits IND for Phase 3 Trial of 2-Dose Varicella Vaccine Reflecting Global Standard Shift 2025-09-02 19:00
Ascletis to Present 28-day Multiple Ascending Dose Study Results of Oral Small Molecule GLP-1R Agonist ASC30 at the 61st European Association for the Study of Diabetes (EASD) Annual Meeting 2025-09-02 18:00
Unlocking the Potential of Cyclic Peptide Therapeutics: Viva Biotech's Discovery Insights 2025-09-02 17:52
Akeso Announces Completion of Patient Enrollment in Phase III Clinical Trial for Ivonescimab as First-Line Treatment for Biliary Tract Cancer Compared to PD-L1 Therapy 2025-09-02 16:00
LOTTE BIOLOGICS establishes contract manufacturing partnership with a leading U.S. Biopharmaceutical Company 2025-09-02 08:00
CMEF 2025: Promoting Holistic and High-Quality Development of Medical and Health Industry 2025-09-01 13:06
Jacobio Pharma Announces 2025 Interim Results 2025-08-30 00:25
Lifezoom Updates: Refining Efficient Light Therapy Products Based on Customer Insights 2025-08-29 23:21
YD Bio Limited Announces Closing of Business Combination and Listing on the Nasdaq Global Market 2025-08-29 19:30
Taiwan's Smart Healthcare Pavilion Presents Precision Oncology and Telemedicine Applications at Taiwan Expo USA 2025 2025-08-29 17:32
MGI Tech and JCBio Announce Collaboration on DCS Lab Project to Advance Multi-Omics Innovation in South Korea 2025-08-29 17:29
UCB presents latest research and clinical advancement across leading epilepsy portfolio at International Epilepsy Congress 2025-08-29 14:00
Celaid Therapeutics have executed a collaborative research agreement with AGC on Expansion and Functional Evaluation of iPSC-HSPCs 2025-08-28 22:00
D3 Bio, Inc. Announces FDA Breakthrough Therapy Designation and Orphan Drug Designation for D3S-001 for the Treatment of Patients with KRAS G12C-Mutated Cancers 2025-08-28 21:00
LakeShore Biopharma Announces Receipt of a Revised Preliminary Non-Binding Proposal to Acquire the Company and Formation of Special Committee 2025-08-28 20:00
WuXi Biologics' Near-Term and Net-Zero Targets Approved by SBTi 2025-08-28 17:00
Exyte and JGC Launch "Nixyte" - New EPC Brand for High-Tech Industries in Southeast Asia 2025-08-28 10:00
ACROBiosystems and DAAN Biotherapeutics Sign Strategic MOU for the Development of Precision Immuno-Oncology Therapeutics 2025-08-28 09:54